1.Objective To evaluate the treatment of non-Hodgkin s lymphoma with combined regimen containing epirubicin as the main drug and to find an effective regimen with low toxicity.
13.So, non-Hodgkin lymphoma is a tumor derived from lymphocytes - specifically B-cells and T-cells, which mainly live in the lymph nodes and move through the blood and lymphatic system.
14.Treatment options for non-Hodgkin lymphoma mainly consists of chemotherapy and radiation therapy, and depend on things like the lymphoma subtype, whether it's indolent, aggressive, or highly aggressive, and how far it has spread.